$ソネット・バイオセラピューティクス・ホールディングス(SONN.US)$Sonnet BioTherapeutics to Present Preclinical Data on SON-080 for Chemotherapy-Induced Peripheral Neuropathy (CIPN) at the AACR 2024 Annual Meeting Accesswire· 1 min ago
Therapeutics Company Presents New Hope For Neuropathy Patients. Sonnet BioTherapeutics (NASDAQ:SONN), a biopharmaceutical company that specializes in developing innovative targeted biologic drugs, recently announced preliminary safety data from the ongoing Phase 1b/2a clinical trial of SON-080. This drug, which is being developed for the treatment of CIPN, met the study's initial pre-specified objective. This development could have s...
$ソネット・バイオセラピューティクス・ホールディングス(SONN.US)$Man I was so green buying this a year and a half ago. looking at the price Target and have learned so much since then but this will forever be one of my bags
ソネット・バイオセラピューティクス・ホールディングスに関するコメント
The AACR Annual Meeting 2024 is scheduled to take place fromApril 5 to April 10, 2024at the San Diego Convention Center in San Diego, California1.This event is organized by the American Association for Cancer Research (AACR) and is a significant gathering for cancer researchers and other healthcare professionals1.Please check the official AACR website or contact the event organizers for the most accurate and up-to-date information1.
Accesswire· 1 min ago
Sonnet BioTherapeutics (NASDAQ: SONN), a biopharmaceutical company that specializes in developing innovative targeted biologic drugs, recently announced preliminary safety data from the ongoing Phase 1b/2a clinical trial of SON-080. This drug, which is being developed for the treatment of CIPN, met the study's initial pre-specified objective. This development could have s...
$バイオムエックス インク(PHGE.US)$ $ラリマー・セラピューティクス(LRMR.US)$ $クレネ(CLNN.US)$ $ガルコトラック(GCTK.US)$ $ソネット・バイオセラピューティクス・ホールディングス(SONN.US)$ $FibroBiologics(FBLG.US)$ $NanoString Technologies(NSTGQ.US)$
📊⚡️📊
$Bit Brother(BETS.US)$
::
まだコメントはありません